-
Health Commission: 28 new confirmed cases and 5 local cases are in Yunnan
Time of Update: 2021-07-29
The latest situation of the novel coronavirus pneumonia epidemic as of 24:00 on July 14 The latest situation of the novel coronavirus pneumonia as of 24:00 on July 14 The latest sit
-
The new crown vaccination broke 1.4 billion doses!
Time of Update: 2021-07-29
Minors are also going to fight Chinanews client, Beijing, July 14 (Reporter Zhang Ni) According to the latest data released by the National Health Commission, as of the 13th, the cumulative number of doses of the new coronavirus vaccine reported in China has exceeded 1.
-
my country has 22 new crown vaccines in clinical trials
Time of Update: 2021-07-29
Yuan Lin, Director of the Department of Drug Supervision and Administration of the State Drug Administration, introduced at the State Council’s policy briefing on the 8th that the State Drug Administration has approved 22 new crown vaccines with 5 technical routes to enter clinical trials, and have conditions attached in accordance with laws and regulations.
-
Development of malaria vaccine: vaccination to weaken live malaria parasites, taking chloroquine, etc.
Time of Update: 2021-07-29
On the evening of June 30th, Beijing time, the top academic journal Nature published an online paper by Duffy and his colleagues titled "Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunity", reporting a malaria vaccine strategy : Inoculation with weakened malaria parasites and then use preventive medications, showing a high level of protection in a trial involving 56 subjects .
-
Experts worry about death of Belgian female infected with dual mutant strain
Time of Update: 2021-07-29
" Wan Kebogen said that it is currently difficult to determine whether the infection of the two variants of the virus is related to the rapid deterioration of the patient's condition .
-
Summary of NMPA's new anti-tumor drugs approved in June, domestic drugs ushered in a small outbreak
Time of Update: 2021-07-29
Drug name: Vidicuzumab (trade name: Aidixi, research code: RC48) R&D company: Rongchang Biological Indications: Gastric cancer (including adenocarcinoma of the gastroesophageal junction) On June 9th, NMPA announced that it had passed the priority review and approval procedure and conditionally approved the listing of Rongchang Bioinjection Vidicuzumab (trade name: Aidixi), which is suitable for HER2 patients who have received at least 2 types of systemic chemotherapy.
-
Health Commission: 9 newly confirmed cases are all imported cases
Time of Update: 2021-07-29
As of 24:00 on June 29, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 455 confirmed cases (including 11 severe cases), 86,689 cured and discharged cases, and 4,636 deaths.
-
Nanda Institute of Virus and Infectious Diseases was established, Zhang Wenhong was appointed honorary director
Time of Update: 2021-07-29
In addition, according to @ Lychee News Weibo news, Zhang Wenhong said that from the history of human struggle with infectious diseases , the virus will exist for a long time .
-
Study finds the mechanism of adenovirus vector new crown vaccine inducing thrombosis
Time of Update: 2021-07-29
Xinhua News Agency, London, July 7 (Reporter Zhang Jiawei) A report published on the website of the British "Nature" magazine on the 7th stated that researchers at McMaster University in Canada analyzed vaccine-induced immune thrombotic thrombocytopenia (VITT) patients After the serum, it was discovered that some people experienced this rare symptom after being vaccinated with the adenovirus vector new crown vaccine, which helped to find a way to prevent this symptom and improve the safety of the vaccine .
-
CDE Teacher Article｜Solution to the Problem of Unclear BCS Classification of Some Varieties in the Consistency Evaluation
Time of Update: 2021-07-29
1 Evaluation method of drug solubility According to the BCS classification of solubility, that is, whether the drug corresponding to the maximum dose of the preparation can be completely dissolved in a water-soluble medium with a volume of no more than 250 mL and a pH value of 1.
-
Notice on Public Solicitation of ICH Guiding Principles "S1B(R1): Drug Carcinogenicity Test: S1B Supplementary Document"
Time of Update: 2021-07-29
The ICH guiding principle "S1B(R1): Drug Carcinogenicity Test: S1B Supplementary Document" is now in the third stage for comments .
We now solicit public opinions on the guiding principles and the Chinese translation .
-
WHO releases guidelines for cervical cancer screening, first HPV-DNA test
Time of Update: 2021-07-29
The World Health Organization and the United Nations Special Programme for Human Reproduction jointly issued a new guide on the 6th to help countries better carry out cervical cancer screening and treatment, which recommends HPV-DNA (human papillomavirus-deoxyribonucleic acid) testing As the preferred screening method for cervical cancer screening .
-
With a sales volume of US$1.86 billion in 2020, Roche enmetrastuzumab will soon be approved for new indications in China
Time of Update: 2021-07-29
As the first single-agent ADC approved for the treatment of HER2-positive metastatic breast cancer that has previously received trastuzumab and taxane chemotherapy (alone or in combination), Kadcyla's sales have increased year by year after its launch, reaching 1.
-
Key mutations may cause cross-species transmission of new coronavirus
Time of Update: 2021-07-29
Liu Xia In the latest study, scientists from Virginia Tech analyzed 182,000 new coronavirus genomes to explore mutations that may help the virus adapt to and spread among humans .
-
Academician Zhang Bo: The development of brain science helps the new generation of artificial intelligence technology change
Time of Update: 2021-07-29
The root cause is that people know too little about the human brain and intelligence, so the key to the development of a new generation of artificial intelligence lies in the integration of brain science research .
-
A new round of volume procurement is coming!
Time of Update: 2021-07-29
Annual sales trend of terminal chemical drugs in public hospitals in Guangdong Province (unit: 100 million yuan) Source: The terminal competition pattern of public hospitals in key provinces and cities of Meinenet From the perspective of manufacturers' sales structure, the total market share of TOP20 manufacturers exceeds 40% .
-
Xin Yuling, a pioneer of thoracic surgery in New China: a hundred-year-old doctor with benevolence and kindness
Time of Update: 2021-07-29
He is Xin Yuling, the Sino-Japanese Friendship Hospital's first president , the cause of thoracic surgery pioneer and founder of New China .
Not long ago, the Xin Yuling Team of the China-Japan Friendship Hospital was formally established .
-
Cuba's research and development of Latin America's first new crown vaccine has an effective rate of over 92%
Time of Update: 2021-07-29
Havana News: On the 21st local time, the Cuban Biomedical Group announced that its self-developed new crown vaccine "Avdala" has an effective rate of 92.
-
More than 1,200 scientists approve Britain to unblock irresponsibility as planned
Time of Update: 2021-07-29
The group of experts issued a statement again on the 13th, stating that 1,246 doctors and scientists from all over the world have joined the open letter joint signature, and urged the British government to wait until most people, including minors, have been vaccinated before implementing the unblocking plan .
-
WHO: There may be a more dangerous and difficult to control variant of the new crown virus
Time of Update: 2021-07-29
WHO: A more dangerous and more difficult-to-control variant of the new coronavirus may appear BEIJING, July 16 (Xinhua) reported, the WHO emergency committee will be the 15th issued a statement saying, "The new crown pandemic have not seen the end .
